Leukemia, Hairy Cell

Hairy cell leukemia is a type of blood cancer involving the excess production of lymphoytes. Here is the latest research on hairy cell leukemia.

January 13, 2021

Genomic profiling is a supplemental diagnostic and therapeutic modality for hairy cell leukemia variant

Annals of Hematology
Amany R KeruakousAdam Asch
November 27, 2020
Case Report
Open Access

Severe Systemic Rash in the Treatment of Hairy Cell Leukemia with Cladribine: Case Report and Literature Review

International Journal of General Medicine
Huijie DongDijiong Wu
November 24, 2020
Open Access

A population-based study of hairy cell leukemia over a period of 20 years

Cancer Treatment and Research Communications
Margaux WiberXavier Troussard
December 12, 2020
Open Access

First report of the unique expression of RECAF (receptor for alfa feto-protein) in adult B-NHL/CLL patients

Blood Research
Hebatallah Adel SedkyWalaa Ali Elsalakawy
November 15, 2020

Cervical Cancer Screening: Comparison of conventional Pap smear test, liquid-based cytology and human papillomavirus testing as stand-alone or co-testing strategies

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Linda A LiangStefanie J Klug
August 29, 2020

The impact of hybrid contact lenses on keratoconus progression after accelerated transepithelial corneal cross-linking

International Ophthalmology
Mehmet Gökhan AslanFeyzahan Uzun
January 14, 2021
Open Access

Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient

Annals of Hematology
Sebastian SchlaweckAnnkristin Heine
October 1, 2020
Preprint
Open Access

Comparative Cost Analysis Of Cervical Cancer Screening Programme Based On Molecular Detection Of HPV In Spain

ResearchSquare
Raquel IbáñezItziar Oyagüez
December 6, 2020
Open Access

Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia-variant

Genes, Chromosomes & Cancer
Maurus LocherNormann Steiner
November 24, 2020

Chronic lymphoproliferative disorders and secondary cancers in the era of purine analogues and beyond

Leukemia & Lymphoma
Sean HarropConstantine S Tam
January 8, 2021

A case of hairy cell leukemia with markedly hypocellular marrow mimicking aplastic anemia

Blood
Christian Salib, Shafinaz Hussein
September 8, 2020

Treatment of hairy cell leukemia

Expert Review of Hematology
Dai Chihara, Robert J Kreitman
November 21, 2020
Open Access

Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm

Hematology/oncology and Stem Cell Therapy
Raja ShekharPankaj Malhotra
August 24, 2020

Ophthalmological findings in patients with leukaemia in a Colombian population

Archivos de la Sociedad Española de Oftalmología
C M RangelH Rodriguez
October 2, 2020

Diagnosis of hairy cell leukaemia by fine needle aspiration cytology of lymph node

Diagnostic Cytopathology
Rachagiri SuneelPranab Dey
January 1, 2021
Case Report
Open Access

Rapid Response in a Patient with Relapsed/Refractory Multiple Myeloma Treated with BRAF/MEK Inhibitors

Case Reports in Hematology
Steve Biko OtienoRobert Johnson

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Bone Marrow Neoplasms

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

Composite Lymphoma

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

FLT3 Inhibitors in Acute Myeloid Leukemia

FMS related tyrosine kinase 3 (FLT3) is a frequently mutated receptor tyrosine kinase in Acute Myeloid Leukemia. Novel Tyrosine kinase inhibitors against FLT3 are currently in clinical trial. Discover the latest research on FLT3 Inhibitors in Acute Myeloid Leukemia here.

Hodgkin Disease

Hodgkin disease or Hodgkin's lymphoma is a type of lymphoma that affects the lymph system. Here is the latest research on Hodgkin disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/leukemia-hairy-cell/74522dac-cdf3-4e8f-8367-8e350a669af8